Ruth Arnon (born 1 June 1933) is an Israeli biochemist and immunologist who codeveloped the multiple sclerosis drug Copaxone, and is the Paul Ehrlich Professor of Immunology at the Weizmann Institute of Science. Born Ruth Rosenberg in Tel Aviv, she studied chemistry at the Hebrew University of Jerusalem, earning her M.Sc. in 1955, and began her doctorate in 1957 under Michael Sela. She joined the Weizmann Institute in 1960 and held many posts there, including head of the Department of Chemical Immunology, dean of the Faculty of Biology, director of the MacArthur Center for Parasitology and vice president of the institute. With Michael Sela and the then doctoral student Devorah Teitelbaum she showed that a synthetic material made in the laboratory could suppress an animal model of multiple sclerosis, work that led after about thirty years to Copaxone, and she has also worked on vaccines against cancer and influenza. She chaired the sciences division of the Israel Academy of Sciences and was later elected its president.
Facts
Field
Field (category) Connections
Member Of
Source Ruth Arnon (Wikipedia)
Works In
Source Ruth Arnon (Wikipedia)
In the Other Atlases
Same As
Also in Medicine Atlas: the same subject.
Nationality
Also in Geography Atlas: the nationality of this subject.
Source Ruth Arnon (Wikipedia)Lead, nationalityQuote, Lead, nationality
is an Israeli biochemist
Sources
1. Ruth Arnon (Wikipedia)
Lead, birth and death dates
born in Tel Aviv on June 1, 1933
Lead, field of work
is an Israeli biochemist and codeveloper of the multiple sclerosis drug Copaxone
Lead and biography, gender
She studied chemistry at the Hebrew University of Jerusalem
Lead, nationality
is an Israeli biochemist
Works In: Immunology, Lead, discipline
She has focused most of her life on the field of immunology
Member Of: Weizmann Institute of Science, Career, institution
Arnon joined the Weizmann Institute of Science in 1960
In Group: Physiology And Medicine, Lead, group placement
One of her largest contributions to science was working alongside Professor Michael Sela to develop a drug for multiple sclerosis called Copaxone
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.